drugset / Trial / NCT00811421

Summary

The study aims at comparing the safety, tolerability and efficacy of Mefloquine (MQ) to Sulfadoxine-Pyrimethamine (SP) as Interment Preventive Treatment in pregnancy (IPTp) for the prevention of malaria effects on the mother and her infant.

Timeline

Start
2009-09
Primary completion
2012-12
Completion
2013-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mefloquine Unknown 15 mg/kg Oral
Comparator pyrimethamine Small molecule 25 mg Oral
Comparator sulfadoxine Small molecule 500 mg Oral